A study identifies a somatic HRAS p.Gly12Ser variant as a cause of mosaic RASopathy in a patient with malignant melanoma. This discovery enhances understanding of the genetic underpinnings of RASopathies and their association with cancer.
mosaic rasopathy caused by a somatic hras p gly12ser variant in a patient with malignant melanoma
Original title: “Mosaic RASopathy Caused by a Somatic HRAS p.Gly12Ser Variant in a Patient With Malignant Melanoma.”